|
CLDND1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.542740E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.68360000000401E-05 |
| Normal-vs-Stage2 |
1.767760E-01 |
| Normal-vs-Stage3 |
9.683000E-01 |
| Normal-vs-Stage4 |
6.370400E-01 |
| Stage1-vs-Stage2 |
3.189800E-01 |
| Stage1-vs-Stage3 |
1.655660E-02 |
| Stage1-vs-Stage4 |
1.819240E-01 |
| Stage2-vs-Stage3 |
2.774200E-01 |
| Stage2-vs-Stage4 |
3.271400E-01 |
| Stage3-vs-Stage4 |
6.392600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.477800E-03 |
| Normal-vs-AfricanAmerican |
2.639900E-03 |
| Normal-vs-Asian |
1.373990E-01 |
| Caucasian-vs-AfricanAmerican |
4.833600E-01 |
| Caucasian-vs-Asian |
9.542800E-01 |
| AfricanAmerican-vs-Asian |
8.329600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.04280000000768E-05 |
| Normal-vs-Female |
6.752200E-01 |
| Male-vs-Female |
3.579900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.239800E-01 |
| Normal-vs-Extreme_Weight |
7.178900E-04 |
| Normal-vs-Obese |
7.322300E-03 |
| Normal-vs-Extreme_Obese |
3.260800E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.946200E-01 |
| Normal_Weight-vs-Obese |
5.471800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.191200E-01 |
| Extreme_Weight-vs-Obese |
5.082800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.192000E-01 |
| Obese-vs-Extreme_Obese |
3.015000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.305000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.466100E-02 |
| Normal-vs-Age(61-80Yrs) |
6.34219999999797E-05 |
| Normal-vs-Age(81-100Yrs) |
1.896970E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.182450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.340500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.490420E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.948200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.726830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.672200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.448000E-04 |
| Normal-VS-Type2 PRCC |
2.400600E-04 |
| Normal-VS-KIRP CIMP |
9.237800E-03 |
| Normal-VS-Unclassified PRCC |
1.341890E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.625000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.880910E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.895000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.53339999983982E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
3.797600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.957980E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.36330000000074E-05 |
| Normal-vs-N1 |
8.661600E-02 |
| Normal-vs-N2 |
6.094800E-01 |
| N0-vs-N1 |
4.976000E-04 |
| N0-vs-N2 |
3.922000E-01 |
| N1-vs-N2 |
8.416000E-01 |
|
|
